Valuation : MiniMed Group, Inc.

Market Cap 6.3B 5.43B 5.11B 4.65B 8.75B 598B 8.8B 60.4B 23.51B 304B 23.64B 23.13B 1,008B P/E 2027 *
34.9x
P/E 2028 * 31.2x
Enterprise Value 5.85B 5.04B 4.74B 4.32B 8.13B 555B 8.17B 56.08B 21.83B 282B 21.95B 21.47B 936B EV / Sales 2027 *
1.7x
EV / Sales 2028 * 1.54x
Free-Float
10.08%
Yield 2027 *
-
Yield 2028 * -
1 day+10.66%
1 week+18.50%
Current month+10.66%
1 month+24.21%
3 months+86.83%
1 week 19.11
Extreme 19.11
22.74
1 month 18.19
Extreme 18.1866
22.74
Current year 10.65
Extreme 10.65
22.74
1 year 10.65
Extreme 10.65
22.74
3 years 10.65
Extreme 10.65
22.74
5 years 10.65
Extreme 10.65
22.74
10 years 10.65
Extreme 10.65
22.74
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Tax

Chief Executive Officer

-31,350 0.0112%
7/31/26 Tax

Chief Technology Officer

-8,012 0.0029%
7/31/26 Tax

General Counsel

-1,762 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
+10.66%+18.50% - - 6.3B
-0.16%-0.55%+18.32%+22.13% 12.71B
-0.90%-1.63%+17.91%+25.52% 6.91B
-5.16%-8.23%+37.36%+23.34% 6.29B
+1.85%-1.51%-18.27%+48.13% 5.17B
+0.65%-1.06%-31.11%-21.94% 3.88B
-1.53%-1.36%+40.96%-22.03% 2.02B
-1.81%-5.10%-0.67%+135.57% 1.79B
-2.82%-4.91%+47.62%-14.95% 1.63B
+0.69%-1.52%-31.57%-41.57% 1.3B
Average +0.15%+1.46%+8.95%+17.13% 4.8B
Weighted average by Cap. +0.59%+1.63%+11.86%+21.30%

Financials

2027 *2028 *
Net sales 3.43B 2.96B 2.78B 2.54B 4.77B 326B 4.79B 32.91B 12.81B 166B 12.88B 12.6B 549B 3.71B 3.2B 3.01B 2.75B 5.16B 353B 5.19B 35.64B 13.87B 179B 13.95B 13.65B 595B
Net income 179M 154M 145M 132M 249M 16.97B 250M 1.72B 668M 8.63B 672M 657M 28.63B 239M 206M 194M 176M 332M 22.65B 334M 2.29B 891M 11.52B 896M 877M 38.2B
Net Debt -450M -388M -365M -333M -626M -42.71B -629M -4.32B -1.68B -21.73B -1.69B -1.65B -72.04B -591M -510M -479M -437M -821M -56.08B -826M -5.67B -2.21B -28.53B -2.22B -2.17B -94.59B
Logo MiniMed Group, Inc.
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Employees
-
Date Price Change Volume
26-09-01 US$22.42 +10.66% 6,075,888
26-08-31 US$20.26 +0.80% 2,482,647
26-08-28 US$20.10 +3.02% 1,329,275
26-08-27 US$19.51 +0.10% 1,306,430
26-08-26 US$19.49 +3.01% 1,244,736
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
22.42USD
Average target price
23.08USD
Spread / Average Target
+2.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MMED Stock